These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29802040)

  • 1. Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review.
    Knorr U; Simonsen AH; Zetterberg H; Blennow K; Hasselbalch SG; Kessing LV
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):783-794. PubMed ID: 29802040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
    Pech J; Forman J; Kessing LV; Knorr U
    J Affect Disord; 2018 Nov; 240():6-16. PubMed ID: 30041075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study.
    Knorr U; Simonsen AH; Roos P; Weimann A; Henriksen T; Christensen EM; Vinberg M; Mikkelsen RL; Kirkegaard T; Jensen RN; Akhøj M; Forman J; Poulsen HE; Hasselbalch SG; Kessing LV
    Transl Psychiatry; 2019 Nov; 9(1):325. PubMed ID: 31780642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control study.
    Knorr U; Simonsen AH; Nilsson J; Brinkmalm A; Zetterberg H; Blennow K; Knudsen MB; Forman J; Hasselbalch SG; Kessing LV
    J Affect Disord; 2024 Aug; 358():250-259. PubMed ID: 38723679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of manic-depressive psychosis from cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid.
    Sjöström R
    Adv Biochem Psychopharmacol; 1974; 11(0):369-75. PubMed ID: 4845705
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dexamethasone on cerebrospinal fluid monoamine metabolites and cortisol in psychiatric patients.
    Banki CM; Arató M; Papp Z; Kurcz M
    Pharmacopsychiatria; 1983 May; 16(3):77-81. PubMed ID: 6193544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review.
    Buoli M; Caldiroli A; Cumerlato Melter C; Serati M; de Nijs J; Altamura AC
    Psychiatry Clin Neurosci; 2016 Jun; 70(6):227-44. PubMed ID: 26969211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.
    Rolstad S; Jakobsson J; Sellgren C; Isgren A; Ekman CJ; Bjerke M; Blennow K; Zetterberg H; Pålsson E; Landén M
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1091-8. PubMed ID: 26024928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF biochemical correlates of mixed affective states.
    Tandon R; Channabasavanna SM; Greden JF
    Acta Psychiatr Scand; 1988 Sep; 78(3):289-97. PubMed ID: 2461640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
    Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
    Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
    [No Abstract]   [Full Text] [Related]  

  • 16. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.
    Mann JJ; Currier D; Murphy L; Huang YY; Galfalvy H; Brent D; Greenhill L; Oquendo M
    J Affect Disord; 2008 Feb; 106(1-2):117-21. PubMed ID: 17604842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.
    Jakobsson J; Bjerke M; Ekman CJ; Sellgren C; Johansson AG; Zetterberg H; Blennow K; Landén M
    Neuropsychopharmacology; 2014 Sep; 39(10):2349-56. PubMed ID: 24694925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.
    Rolstad S; Jakobsson J; Sellgren C; Ekman CJ; Blennow K; Zetterberg H; Pålsson E; Landén M
    PLoS One; 2015; 10(5):e0127100. PubMed ID: 25954806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.